Known to be associated with a poor prognosis in papillary thyroid cancer, Yang et al. demonstrated that the density of CD8+ tumor-infiltrating T-lymphocytes was reduced in thyroid cancers with BRAFV600E mutation compared with BRAFV600E wild-type cancers [23]. This evidence concerns the gene CD8A and thyroid gland papillary carcinoma.